GRANULOMATOUS MASTITIS
Clinical trials for GRANULOMATOUS MASTITIS explained in plain language.
Never miss a new study
Get alerted when new GRANULOMATOUS MASTITIS trials appear
Sign up with your email to follow new studies for GRANULOMATOUS MASTITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for women with stubborn breast inflammation
Disease control Not yet recruitingThis study tests a drug called tocilizumab in 31 women aged 20-50 with a rare, painful breast inflammation that doesn't get better with steroids or causes bad side effects. The drug blocks a protein involved in inflammation. The main goal is to see if it can calm the inflammation…
Matched conditions: GRANULOMATOUS MASTITIS
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New study aims to end the guesswork in treating rare breast disease
Disease control Not yet recruitingThis study tests whether antibiotics or steroids work better for granulomatous lobular mastitis, a rare, painful breast inflammation in women. 72 women will receive either an 8-week course of antibiotics or tapering steroids, with follow-up for 6 months. The goal is to find a sta…
Matched conditions: GRANULOMATOUS MASTITIS
Phase: PHASE1, PHASE2 • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New european registry aims to unlock mysteries of rare breast disease
Knowledge-focused Not yet recruitingThis study is creating a European registry for people with idiopathic granulomatous mastitis (IGM), a rare inflammatory breast condition that causes pain, redness, and abscesses. Researchers will collect information from 1,000 participants to better understand symptoms, treatment…
Matched conditions: GRANULOMATOUS MASTITIS
Sponsor: European Breast Cancer Research Association of Surgical Trialists • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:38 UTC